VekluryActive Ingredient(s): Remdesivir
FDA Approved: * October 22, 2020
Pharm Company: * GILEAD SCIENCES INC
Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. During the COVID19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID19 in numerous countries. Remdesivir was originally developed to treat hepatitis C,&... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.